US Broker Ratings

Exact Sciences Corporation (EXAS) Stock Analysis: Strong Buy Ratings and 28.66% Potential Upside

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the healthcare sector, operates at the forefront of the diagnostics and research industry. Known for its innovative..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A 62% Upside Potential Awaits Amid Innovative Biotech Developments

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leader in RNA-targeted therapeutics, remains a compelling consideration for investors in the volatile biotech sector. With a market capitalization of..

Haleon plc (HLN) Investor Outlook: Understanding Its 6.46% Potential Upside and Market Position

Haleon plc (NYSE: HLN), a prominent player in the healthcare sector, is capturing the attention of investors with its robust market presence and a notable potential..

Royalty Pharma plc (RPRX) Stock Analysis: A Compelling 19% Upside with Strong Buy Ratings

Investors eyeing opportunities in the healthcare sector may find Royalty Pharma plc (NASDAQ: RPRX) an intriguing prospect. With a market capitalization of $19.59 billion, Royalty Pharma..

Charles River Laboratories (CRL) Stock Analysis: Navigating the Healthcare Sector with a 4.48% Upside Potential

Charles River Laboratories International, Inc. (NYSE: CRL) is a prominent name in the healthcare sector, specializing in diagnostics and research services. With a market capitalization of..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a Promising 21% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN), an Italian stalwart in the healthcare sector, has captured the attention of investors with its robust business model and promising market..

DexCom, Inc. (DXCM) Stock Analysis: Exploring a 20% Potential Upside Amid Strong Buy Ratings

DexCom, Inc. (DXCM), a titan in the healthcare sector, specifically within the medical devices industry, is making waves with its robust growth trajectory and innovative offerings..

Chemed Corp (CHE) Stock Analysis: Unlocking a 22.89% Potential Upside

Chemed Corporation (NYSE: CHE) stands out in the healthcare sector, particularly within the medical care facilities industry, with a robust market capitalization of $8.06 billion. As..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a 78% Potential Upside Amidst Volatility

Moderna, Inc. (NASDAQ: MRNA), a pioneering biotechnology company, has captured investor attention with its expansive portfolio of messenger RNA (mRNA) medicines. As the healthcare sector continues..

Baxter International Inc. (BAX) Stock Analysis: Navigating Opportunities with a 25% Upside Potential

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, is navigating choppy waters with its diverse portfolio of medical instruments and supplies. Headquartered in..

UnitedHealth Group (UNH) Stock Analysis: Evaluating a 22.90% Upside in the Healthcare Giant

UnitedHealth Group Incorporated (NYSE: UNH) stands as a titan in the healthcare sector, commanding a market capitalization of $284.42 billion. This American healthcare plans behemoth operates..

Elevance Health, Inc. (ELV) Stock Analysis: Unpacking a 30% Potential Upside

Elevance Health, Inc. (NYSE: ELV), previously known as Anthem, Inc., stands as a formidable player in the healthcare plans industry. With a substantial market capitalization of..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unveiling a Potential 48.87% Upside in Biotech Innovation

BridgeBio Pharma, Inc. (NASDAQ: BBIO), headquartered in Palo Alto, California, has emerged as a pivotal player in the biotechnology sector, focusing on transformative treatments for severe..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 16.86% Potential Upside Amid Strong Analyst Ratings

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, stands out in the diagnostics and research industry with a market capitalization of $33.26..

Globus Medical, Inc. (GMED) Stock Analysis: A Look at its 44.60% Potential Upside

For investors scouting opportunities within the healthcare sector, Globus Medical, Inc. (NYSE: GMED) presents a compelling case, particularly with its substantial 44.60% potential upside. This medical..

ICON plc (ICLR) Stock Analysis: Unveiling a 21.88% Potential Upside in Healthcare Research

ICON plc (ICLR), a prominent player in the healthcare sector’s diagnostics and research industry, stands out with a substantial market capitalization of $11.57 billion. Headquartered in..

Incyte Corporation (INCY) Stock Analysis: Unveiling a Biotech Gem with 11.36% Potential Upside

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, presents a compelling case for investors seeking growth within the healthcare industry. With a market..

Viatris Inc. (VTRS) Stock Analysis: Navigating a 27.66% Potential Upside Amidst a Challenging Market Landscape

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, operates on a global scale with a diverse portfolio of prescription brand drugs, generic drugs,..

Biogen Inc. (BIIB) Stock Analysis: Evaluating a 31.61% Potential Upside Amidst Healthcare Innovations

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, continues to capture investor attention with its innovative approaches in treating neurological and neurodegenerative diseases. As..

AptarGroup (ATR) Stock Analysis: Exploring a 15.77% Potential Upside in the Healthcare Sector

For investors with a keen eye on the healthcare sector, AptarGroup, Inc. (NYSE: ATR) presents an intriguing opportunity. As a prominent player in the medical instruments..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds